ICAS
RXII

Investors Capital Advisory Services’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Investors Capital Advisory Services’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-13,200
Closed -$65K – 714
2013
Q4 		$65K Buy
+13,200
New +$65K 0.02% 601

Other funds holding RXII

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Investors Capital Advisory Services's RXII Position: Q1 2014 in Review

Investors Capital Advisory Services sold out of GALENA BIOPHARMA INC COM (RXII) in Q1 2014, closing a stake of 13,200 shares — an estimated $65K sold.

Investors Capital Advisory Services first reported a position in RXII in Q4 2013 and held it in 1 quarter. The position peaked at $65K in Q4 2013. 88 funds tracked by Wall St. Rank hold RXII as of Q1 2014.

  • Investors Capital Advisory Services reported no remaining GALENA BIOPHARMA INC COM position as of Q1 2014 after selling out during the quarter.
  • Investors Capital Advisory Services sold 13,200 GALENA BIOPHARMA INC COM shares in Q1 2014, an estimated $65K.
  • Investors Capital Advisory Services first reported a position in GALENA BIOPHARMA INC COM in Q4 2013 and held it in 1 quarter.
  • Investors Capital Advisory Services's GALENA BIOPHARMA INC COM position peaked at $65K in Q4 2013.
  • 88 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q1 2014.

Based on Investors Capital Advisory Services's 13F filing for Q1 2014, filed 15 Apr 2014.